COST DARTER (@AON_Delivery) header
COST DARTER (@AON_Delivery) profile picture

Official account of @COSTprogramme Action 17103 "#Delivery of #RNATherapeutics"

Joined August 2018
Photo by COST DARTER (@AON_Delivery)Photo by COST DARTER (@AON_Delivery)Photo by COST DARTER (@AON_Delivery)Photo by COST DARTER (@AON_Delivery)Photo by COST DARTER (@AON_Delivery)Photo by COST DARTER (@AON_Delivery)Photo by COST DARTER (@AON_Delivery)Photo by COST DARTER (@AON_Delivery)Photo by COST DARTER (@AON_Delivery)Photo by COST DARTER (@AON_Delivery)
COST DARTER retweeted
Thanks thanks thanks to @FundlaCaixa for its commitment to science and … for seeing how amazing our project is! Thanks to @OscarLlorcaCNIO and @FMorenoHerrero for this journey!
16/ 🏆Llegamos al ecuador de la ceremonia con los 6 reconocimientos en oncología, entregados por: 🔵 Juan Ramón Fuertes, director general adjunto @FundlaCaixa 🔵 Ignasi López, director del Área de Relaciones con Instituciones de Investigación y Salud @FundlaCaixa
5
5
19
1,236
Si os interesa, podéis ver la charla completa aquí: "ADN y ARN: descifrando los códigos de la enfermedad y el tratamiento" ➡️ youtu.be/YQPpXOtcdVo?si=1K0x…
2
3
1
6
342
🧬Las células tumorales pueden reparar los daños en su material genético causados por la quimioterapia y la radioterapia, lo que les permite generar resistencia a los tratamientos. Con una ayuda #CaixaResearch, @FortesLab estudiará estos mecanismos en los cánceres de hígado➕letales para diseñar nuevas terapias de ARN más efectivas. 👇 tinyurl.com/2vjwwya5
1
6
2
20
3,186
#apaperaday Today's pick is from Journal of Cystic Fibrosis by Caraco et al on a clinical trial in healthy volunteers to test safety and tolerability of inhalation of an cryptic splicing restoring antisense oligonucleotide (ASO) for cystic fibrosis DOI: 10.1016/j.jcf.2024.10.004
1
1
3
356
🧬 El sábado hablé en #NaukasValladolid sobre #terapias de ácidos nucleicos para #enfermedadesraras. 🌟 Es el nombre y la misión de mi grupo de investigación en @biobizkaia , y en esta charla intenté explicar nuestra visión y el futuro de este campo. 👇
1
6
14
877
Our review on RNA therapies for urea cicle disorders is now online! #RareDiseases 👇👇 @AON_Delivery @EvaRichard12 @CBM_CSIC_UAM @CIBERER @UAM_Madrid
9
24
1,395
The oligo field is rapidly moving forward! #OTS24
Remember when marketed oligonucleotides fitted easily on a slide with very large font? We now need 2 columns and a small font. Soon we need multiple slides #ots24 #oligomeeting
4
15
916
Maire Fiona Jung discussed one of the most important aspects in the field, delivery. She shows promising data for delivery of ASOs to other tissues then the liver! #OTS24 – at Montréal, Québec
2
6
689
Be Part of OTS History! Contribute to the 2024 Video Time Capsule To celebrate the 20th Annual Meeting, the Oligonucleotide Therapeutic Society is creating a video time capsule, and we want YOU to be a part of it! #ots #oligotherapeutics #oligonucleotide #biotech #biotechnology
1
5
8
597
Join our Team! The Nucleic Acid Therapeutics in Rare Diseases (NAT-RD) Group @biobizkaia is looking for researchers! 🧬 #WMS2024 #OTS24 Several positions 👇👇
2
6
1
7
797
COST DARTER retweeted
Shalini Andersson from @AstraZeneca is giving the keynote lecture, which is masterclass on #antisense #oligonucleotides at the #DATS2024, highlighting one of the greatest efforts of @AON_Delivery! You can find this fogure: embopress.org/doi/full/10.15…
2
2
7
325
On my way to @UniTrento for a PhD viva tomorrow... Looking forward finally return the visit to @michela_denti and seeing @roon_mom in 3D and @AGoyenvalle in 2D... Nice things you still reap from @COSTprogramme Action @AON_Delivery. #sciencetwitter #academia
2
12
524
Being in a room packed with other researchers interested in publishing "negative" results, Open Science and research integrity for two days... I'm enjoying it so much only some @AON_Delivery members would understand... (Hey, we are not alone)...
1
2
5
274
The @NINDS4Rigor workshop on “Novel Approaches to Preventing Publication Bias” is less than one month away! You may register for online viewing to get the videocast link on your calendar! forms.roseliassociates.com/v…
THANK YOU to everyone who submitted a response to our Request for Information on publication bias! We will be discussing the responses and other potential solutions at our workshop on “Novel Approaches to Preventing Publication Bias” on May 20-21, 2024! ninds.nih.gov/news-events/ev…
2
1
4
1,676
As you know, I think we should try to publish all good research, even when the results are not what we expected, or not sexy enough for a "high impact" publication, so I am very excited to participate in this meeting:
The @NINDS4Rigor workshop on “Novel Approaches to Preventing Publication Bias” is less than one month away! You may register for online viewing to get the videocast link on your calendar! forms.roseliassociates.com/v…
4
12
502
New paper from the lab in Nucleic Acid Therapeutics @OTSociety journal, in collaboration with @AndresenBrage 👇👇👇 Antisense oligonucleotides as potential therapy for PKU splice variants @AON_Delivery @CBMSeveroOchoa @CIBERER @CedemEMH #PKU #AON #CRISPR
2
10
26
1,900
This is a very nice research group in @biogipuzkoa searching for a postdoc.... Could you RT? #sciencejobs #postdoc
Job alert 🚨!! We are looking for a postdoc in computational biology. If you are interested in #Neurogenetics, #RNA biology, short and #Nanopore sequencing, check our open position and apply 👇 tinyurl.com/rcshuym2 Any questions DM or email me!
8
10
918
First authors report on a study in the mdx mouse model. They used males, included wild type controls and also compared to a scrambled ASO and 12 mice per group. Hooray so far. However, when doing the analysis authors compared to saline rather than scrambled control 👇🫤
1
1
4
119
#apaperaday from home with Yuzu refusing to pose properly. Today's pick is from @PLOSONE by Woodcock et al on a phase 2 trial in non ambulant patients with Duchenne with an antisense oligonucleotide ATL1102 with ant-inflammatory properties DOI: 10.1371/journal.pone.0294847
2
1
4
487